35 related articles for article (PubMed ID: 18998444)
1. Don't blame it all on the bogey.
Day M
BMJ; 2007 Jun; 334(7606):1250-1. PubMed ID: 17569929
[TBL] [Abstract][Full Text] [Related]
2. What ails the FDA?
Gorelick KJ
N Engl J Med; 2005 Jun; 352(24):2553-4. PubMed ID: 15958814
[No Abstract] [Full Text] [Related]
3. Why is this woman smiling? The hard sell of bad medicine.
Bloice C
Revolution (Oakl); 2005; 6(1):22-9. PubMed ID: 15822700
[No Abstract] [Full Text] [Related]
4. Withdrawal of rofecoxib - a wake up call for drug safety.
Mishra P; Palaian S
Kathmandu Univ Med J (KUMJ); 2004; 2(4):360. PubMed ID: 16388250
[No Abstract] [Full Text] [Related]
5. Evaluating drug effects in the post-Vioxx world: there must be a better way.
Avorn J
Circulation; 2006 May; 113(18):2173-6. PubMed ID: 16684873
[No Abstract] [Full Text] [Related]
6. Former pharma pitchman: beware of new drugs. An industry insider advises considering the older options if you need a prescription. Interview by Sarah Baldauf.
Nesi T
US News World Rep; 2008 Nov 3-10; 145(10):64. PubMed ID: 18998444
[No Abstract] [Full Text] [Related]
7. Editorial overview: from Vioxx to Luckenbach: drug discovery at a crossroads.
Williams M
Curr Opin Investig Drugs; 2005 Jan; 6(1):17-20. PubMed ID: 15675599
[No Abstract] [Full Text] [Related]
8. Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
Borer JS; Pouleur H; Abadie E; Follath F; Wittes J; Pfeffer MA; Pitt B; Zannad F
Eur Heart J; 2007 Aug; 28(15):1904-9. PubMed ID: 17615083
[TBL] [Abstract][Full Text] [Related]
9. Drug development for children: how is pharma tackling an unmet need?
Hawcutt DB; Smyth RL
IDrugs; 2008 Jul; 11(7):502-7. PubMed ID: 18600597
[TBL] [Abstract][Full Text] [Related]
10. COX-2 selective inhibitors and heart health.
Simon LS; White WB
Postgrad Med; 2005 Jan; 117(1 Suppl):7-20. PubMed ID: 19667717
[TBL] [Abstract][Full Text] [Related]
11. Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma.
Eichler HG; Pignatti F; Flamion B; Leufkens H; Breckenridge A
Nat Rev Drug Discov; 2008 Oct; 7(10):818-26. PubMed ID: 18787530
[TBL] [Abstract][Full Text] [Related]
12. Essay: the political logic of regulatory error.
Carpenter D; Ting MM
Nat Rev Drug Discov; 2005 Oct; 4(10):819-23. PubMed ID: 16184084
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
